NeuroSense Therapeutics L...

NASDAQ: NRSNW · Real-Time Price · USD
0.69
0.00 (0.00%)
At close: Aug 15, 2025, 3:20 PM
0.75
8.70%
After-hours: Aug 15, 2025, 04:00 PM EDT

NeuroSense Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-10.21M -10.11M -12.34M -4.04M
Depreciation & Amortization
22K 21K 89K 3K
Stock-Based Compensation
557K 1.54M 5.11M 4.16M
Other Working Capital
-482K 928K 291K 289K
Other Non-Cash Items
277K -1.71M -1.19M 791K
Deferred Income Tax
n/a n/a n/a -2.72M
Change in Working Capital
-781K 1.91M 750K 273K
Operating Cash Flow
-10.13M -8.35M -7.59M -1.54M
Capital Expenditures
-3K -29K -70K -17K
Cash Acquisitions
n/a 3K n/a n/a
Purchase of Investments
n/a n/a -3.5M n/a
Sales Maturities Of Investments
n/a 3.5M n/a n/a
Other Investing Acitivies
4K -6K 29K n/a
Investing Cash Flow
1K 3.47M -3.54M -17K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-391K n/a 3.69M 2.04M
Financial Cash Flow
10.91M 3.98M 3.69M 11.9M
Net Cash Flow
738K -903K -7.52M 10.36M
Free Cash Flow
-10.14M -8.38M -7.66M -1.56M